Pharmaceutical

Image

Global Viscosupplementation Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 987
  • No of Figures: 73

Global Viscosupplementation Market, By Source (Animal Origin And Non-Animal Origin), Age Group (Geriatric And Adults), Injection (Single Injection, Three Injections, And Five Injections), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight And High Molecular Weight), End User (Hospital, Orthopedic Clinics, Ambulatory Care Centers, And Others), Distribution Channel (Direct Tender And Retail Sales) - Industry Trends and Forecast to 2029.

Viscosupplementation Market

Viscosupplementation Market Analysis and Insights

Global viscosupplementation market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.5% in the forecast period of 2022 to 2029. Technological advancements in viscosupplementation treatments rise in the healthcare sector are another factor that drives the growth of the global viscosupplementation market in the forecast period.

Viscosupplementation Market

Viscosupplementation Market

However, the high cost associated with the treatments and side effects such as temporary injection, site pain, swelling, heat, and redness loss will restrain the market's growth. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of the global viscosupplementation market.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020

Quantitative Units

Revenue in USD Million Volumes in Units, Pricing in USD

Segments Covered

By Source (Animal Origin And Non-Animal Origin), Age Group (Geriatric And Adults), Injection (Single Injection, Three Injections, And Five Injections), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight And High Molecular Weight), End User (Hospital, Orthopedic Clinics, Ambulatory Care Centers, And Others), Distribution Channel (Direct Tender And Retail Sales)

Countries Covered

U.S., Canada, Mexico, Panama, Jamaica, and the Dominican Republic, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Austria, Hungary, Lithuania, Norway, Ireland, and the rest of Europe, China, Japan, India, South Korea, Singapore, Australia, Thailand, Vietnam, Malaysia, Taiwan, Indonesia, Philippines, and Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, South Africa, Kuwait, and rest of the Middle East and Africa, Brazil, Argentina, Peru, Colombia, Chile, Ecuador, Uruguay, Venezuela, Bolivia, Paraguay, Trinidad and Tobago, Curaçao, and the rest of South America.

Market Players Covered

Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V,  sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS),  APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW BIOTECH, Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals), among others.

Viscosupplementation Market Definition

The development of the therapeutic paradigm viscosupplementation for long-lasting pain relief in human and animal joints with osteoarthritis or traumatic arthritis was based on the finding that in arthritic conditions, the average molecular weight and concentration of hyaluronan decreased. Consequently, the elastoviscous properties of the synovial fluid are substantially reduced. Viscosupplementation is a therapeutic process in which the pathological synovial fluid or effusion is removed from the joint by arthrocentesis and is replaced with a highly purified hyaluronan solution which has a 16- to 30-times greater concentration than the pathological joint fluid, and a 2- to 5-times greater concentration than that of the hyaluronan in the healthy synovial fluid. In some preparations of hyaluronan used today for therapeutic purposes, the rheological properties (viscosity and elasticity) are low. Therefore the elastoviscosity of the fluid is similar to that of fluid removed from an arthritic joint. Another preparation available to patients worldwide is composed of hyaluronan derivatives (hylans) with substantially greater elastoviscosity than hyaluronan solutions. It has comparable rheological properties to the fluid found in young, healthy individuals. The clinical benefit of viscosupplementation is long-lasting pain relief in arthritic joints.

Furthermore, the increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced disorders, and advancements in the development of hyaluronic acid-based therapies are some of the factors expected to drive the market. 

Market Dynamics                                        

Drivers

  • Rising geriatric population

With this increasing age comes a reciprocal increase in the elderly patients admitted to the hospitals due to fatal traumatic injuries. The rising prevalence of knee osteoarthritis diseases leads to increasing demand for diagnosis and treatment. With the growing population, the pressure on the healthcare system is rising. The increasing need for the proper treatment proportionally surges the demand for care, services, and technologies for the prevention and treatment of knee osteoarthritis conditions such as sarcopenia, osteoporosis, osteopenia, and other complications. The elderly population is more prone to these conditions leading to fragile bones and joints. In such patients, viscosupplementation is used in the procedure to provide them with immediate and efficient benefits associated with their bodies.

With this increasing age and rising prevalence of osteoarthritis, the demand for early diagnosis of the diseases is also increasing. Therefore, the demand for viscosupplementation is rising for the treatment in the healthcare system across the globe.

  • Increasing risk of osteoporosis and osteoarthritis

Osteoporosis is a disease of bone that progresses due to less bone mineral density and bone mass or due to some variation in the quality or structure of bone. Osteoporosis could increase the risk of fractures leading to broken bones due to decreased bone strength. It is more observed in women as compared to men. The post-menstrual women often get bone fractures due to osteoporosis as the disease is silent and typically shows no symptoms. Mostly elderly people are more prone to osteoporosis. Osteoarthritis is a joint disease or an inflammation of the joints and surrounding tissues. The mobility of a person is affected when such conditions occur.

The silent diseases such as osteoporosis and osteoarthritis show no symptoms and weaken the person's bone, leading to major fatalities such as spine malformation, fracture, sudden fall, or breakage of bone, among others. Thus, the increased risks of these conditions directly enhance the demand for viscosupplementation required to treat the malformations due to such conditions. Therefore, the increasing risk of osteoporosis and osteoarthritis is anticipated to drive the growth of the global viscosupplementation market.

Restraint

  • Lack of technical expertise

Finding, attracting, and hiring talent is also the first step in building a professional bench of engineers and technicians. Even in the best of circumstances, this procedure can be challenging. Manufacturing existing workforce is rapidly aging and retiring. In the medical industry, there is a scarcity of STEM (science, technology, engineering, and mathematics) skills. Although demand for skilled tradespeople (technicians) and undergraduate/post-graduate skills (engineers) remains strong in manufacturing, the number of people with the necessary skills is approaching a trickle. Only trained professionals should perform viscosupplementation, but this number is much less across the globe as these procedures are complex.

However, putting together a good additive manufacturing (AM) workforce entails more than just finding and recruiting qualified candidates. Employees must be qualified to remain current and maintain required skills as technology shift and grow. Even with their STEM-focused education, newly minted engineers would certainly need on-the-job training in AM techniques, which is one of the major challenges of recruiting and hiring them. Indeed, many undergraduate engineering programs provide little in the way of AM-specific education, and as a result, many graduates can lack the AM skills that employers seek.

Thus, the lack of technical expertise may act as a restraint for the market's growth.

Viscosupplementation Market

Opportunity

  • Safety and effectiveness of intra-articular hyaluronic acid (IAHA)

There are several types of hyaluronic acid injections, also called viscosupplementation, which are used for knee osteoarthritis. They are made from either rooster or chicken combs or are derived from bacteria and are injected directly into the joint. Intra-articular hyaluronic acid is a US Food and Drug Administration-approved treatment for knee osteoarthritis (OA). Intra-articular hyaluronic acid (IAHA) injection presents an alternative local treatment option providing symptomatic benefit without the systemic AEs associated with IA corticosteroids. Numerous RCTs and meta-analyses have sought to assess the efficacy and safety of IAHA, with mixed results and conclusions. IAHA is demonstrated to have a positive effect on pain and joint function. There is also mounting data showing that multiple courses of IAHA can impact long-term outcomes, including a reduction in concomitant analgesia use and a delay in the need for total knee replacement surgery.

Challenge

  • Stringent government policies for THE USE OF viscosupplementation

The commercialization of viscosupplementation across the globe by various key market players is facilitated by compliance with the regulatory frameworks established by many countries across the globe. The pre-market approval of various medical devices varies from one country to another. The U.S. Food, Drug, and Cosmetic Act ("FD&C Act") classify medical devices in the U.S. The European Union (EU) regulates medical devices in Europe. However, the rapid development of privacy policies and regulations are being made in the Asia-Pacific and EMEA, including India, Russia, China, South Korea, Singapore, Hong Kong, and Australia.

The viscosupplementation is regulated by a structure of laws, rules, and regulations that are extensive and complex to safeguard them from use in any potential harmful treatment.

The viscosupplementation act as a replacement for the damaged, injured, or infected body parts in cases of osteoarthritis conditions or sports accidents among patients, along with maintaining the patient's demand for good body movement. However, any misguidance will affect the patient's safety and body structure.

Therefore, the stringent rules & regulations for the use of viscosupplementation may act as a challenge to the growth of the market.

Post COVID-19 Impact on Global Viscosupplementation Market

COVID-19 has resulted in a substantial increase in demand for medical supplies from healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the global viscosupplementation market.

Global Viscosupplementation Market Scope and Market Size

Global viscosupplementation market is segmented on the basis of source, age group, molecular weight, injection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the Difference in your target markets.

BY SOURCE

  • ANIMAL ORIGIN
  • NON-ANIMAL ORIGIN

On the basis of source, the global viscosupplementation market is segmented into the animal origin and non-animal origin.

BY MOLECULAR WEIGHT

  • HIGH MOLECULAR WEIGHT
  • LOW MOLECULAR WEIGHT
  • INTERMEDIATE MOLECULAR WEIGHT

On the basis of molecular weight, the global viscosupplementation market is segmented into intermediate molecular weight, low molecular weight, and high molecular weight.

BY INJECTION

  • SINGLE INJECTION
  • THREE INJECTION
  • FIVE INJECTION

On the basis of injection, the global viscosupplementation market is segmented into single injection, three injections, and five injections.

BY AGE GROUP

  • ADULTS
  • GERIATRICS

On the basis of age group, the global viscosupplementation market is segmented into geriatric and adults.

END-USER

On the basis of end-user, the global viscosupplementation market is segmented into hospital, orthopedic clinics, ambulatory care centers, and others.

BY DISTRIBUTION CHANNEL

  • DIRECT TENDER
  • RETAIL SALES

Viscosupplementation Market

On the basis of distribution channel, the global viscosupplementation market is segmented into direct tender and retail sales.

Global Viscosupplementation Market Country Level Analysis

The viscosupplementation market is analyzed, and market size information is provided by source, age group, molecular weight, injection, end user, and distribution channel.

The countries covered in the viscosupplementation market report are the U.S., Canada, Mexico, Panama, Jamaica, and the Dominican Republic, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Austria, Hungary, Lithuania, Norway, Ireland, and the rest of Europe, China, Japan, India, South Korea, Singapore, Australia, Thailand, Vietnam, Malaysia, Taiwan, Indonesia, Philippines, and Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, South Africa, Kuwait, and rest of the Middle East and Africa, Brazil, Argentina, Peru, Colombia, Chile, Ecuador, Uruguay, Venezuela, Bolivia, Paraguay, Trinidad and Tobago, Curaçao, and the rest of South America.

In 2022, North America is dominating due to the presence of key market players in the largest consumer market with high GDP. The U.S is expected to grow due to the rise in technological advancement in drug treatments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact on sales channels are considered while providing forecast analysis of the country data.

Viscosupplementation Market

Global viscosupplementation market also provides you with a detailed market analysis of every country growth in the healthcare industry. Moreover, it provides detailed information regarding healthcare services and treatments, the impact of regulatory scenarios, and trending parameters regarding the global viscosupplementation market.

Competitive Landscape and Global Viscosupplementation Market Share Analysis

Global viscosupplementation market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to viscosupplementation treatments.

The major companies which are dealing in the viscosupplementation market are Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V,  sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS),  APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW BIOTECH, Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals), among others

Strategic alliances like mergers, acquisitions, and agreements by the key market players are further expected to accelerate the growth of viscosupplementation treatments.

For instance,

  • In June 2022, Johnson & Johnson announced new data from Phase 3 studies demonstrating patients treated with medicine achieved consistent, long-term efficacy through two years across the domains of active psoriatic arthritis (PsA) – including joint, skin, enthesitis, a dactylitis,b spinal pain, and disease severityc endpoints – irrespective of baseline characteristics. This has helped company to showcase its progress
  • In November 2020, Viatris Inc. launched a successful combination of Mylan N.V. and Pfizer's Upjohn business. By combining these two complementary legacy companies, Viatris has the scientific, manufacturing, and distribution expertise with proven regulatory, medical and global commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. This has helped company to expand its business

Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player are enhancing the company's footprints in the global viscosupplementation market, which also benefits the organization’s profit growth.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Asia-Pacific vs. Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.


SKU-

TABLE 1 GLOBAL VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL NON-ANIMAL IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 5 GLOBAL ANIMAL IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 9 GLOBAL HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 11 GLOBAL VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL SINGLE INJECTION IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL THREE INJECTION IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL FIVE INJECTION IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL ADULT IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL GERIATRIC IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 GLOBAL VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 26 GLOBAL HOSPITALS IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 GLOBAL ORTHOPEADIC CLINICS IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 GLOBAL AMBULATORY CARE CENTERS IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 GLOBAL OTHERS IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 GLOBAL VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 31 GLOBAL RETAIL SALES IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 GLOBAL DIRECT TENDER IN VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 GLOBAL VISCOSUPPLEMENTATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 38 NORTH AMERICA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 41 NORTH AMERICA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 43 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 51 U.S. VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 52 U.S. NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 53 U.S. NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 54 U.S. NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 55 U.S. ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 U.S. HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 57 U.S. HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 58 U.S. HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 59 U.S. VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 60 U.S. INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 61 U.S. LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 62 U.S. HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 63 U.S. VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 64 U.S. VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 65 U.S. VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 66 U.S. VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 67 CANADA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 68 CANADA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 69 CANADA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 70 CANADA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 71 CANADA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 CANADA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 73 CANADA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 74 CANADA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 75 CANADA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 76 CANADA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 77 CANADA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 78 CANADA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 79 CANADA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 80 CANADA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 81 CANADA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 82 CANADA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 83 MEXICO VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 84 MEXICO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 85 MEXICO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 86 MEXICO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 87 MEXICO ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 MEXICO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 89 MEXICO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 90 MEXICO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 91 MEXICO HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 92 MEXICO HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 93 MEXICO HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 94 MEXICO VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 95 MEXICO INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 96 MEXICO LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 97 MEXICO HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 98 MEXICO VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 99 MEXICO VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 100 MEXICO VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 101 MEXICO VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 102 PANAMA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 103 PANAMA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 104 PANAMA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 105 PANAMA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 106 PANAMA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 107 PANAMA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 108 PANAMA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 109 PANAMA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 110 PANAMA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 111 PANAMA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 112 PANAMA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 113 PANAMA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 114 PANAMA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 115 PANAMA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 116 PANAMA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 117 PANAMA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 118 PANAMA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 119 PANAMA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 120 PANAMA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 121 JAMAICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 122 JAMAICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 123 JAMAICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 124 JAMAICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 125 JAMAICA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 JAMAICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 127 JAMAICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 128 JAMAICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 129 JAMAICA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 130 JAMAICA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 131 JAMAICA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 132 JAMAICA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 133 JAMAICA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 134 JAMAICA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 135 JAMAICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 136 DOMINICAN REPUBLIC VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 137 DOMINICAN REPUBLIC NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 138 DOMINICAN REPUBLIC NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 139 DOMINICAN REPUBLIC NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 140 DOMINICAN REPUBLIC ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 141 DOMINICAN REPUBLIC HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 142 DOMINICAN REPUBLIC HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 143 DOMINICAN REPUBLIC HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 144 DOMINICAN REPUBLIC VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 145 DOMINICAN REPUBLIC INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 146 DOMINICAN REPUBLIC HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 147 DOMINICAN REPUBLIC VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 148 DOMINICAN REPUBLIC VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 149 DOMINICAN REPUBLIC VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 150 DOMINICAN REPUBLIC VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 151 EUROPE VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 152 EUROPE VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 153 EUROPE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 154 EUROPE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 155 EUROPE ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 156 EUROPE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 157 EUROPE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 158 EUROPE HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 159 EUROPE HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 160 EUROPE VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 161 EUROPE INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 162 EUROPE LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 163 EUROPE HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 164 EUROPE VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 165 EUROPE VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 166 EUROPE VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 167 EUROPE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 168 GERMANY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 169 GERMANY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 170 GERMANY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 171 GERMANY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 172 GERMANY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 173 GERMANY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 174 GERMANY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 175 GERMANY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 176 GERMANY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 177 GERMANY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 178 GERMANY LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 179 GERMANY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 180 GERMANY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 181 GERMANY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 182 GERMANY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 183 GERMANY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 184 FRANCE VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 185 FRANCE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 186 FRANCE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 187 FRANCE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 188 FRANCE ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 FRANCE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 190 FRANCE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 191 FRANCE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 192 FRANCE VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 193 FRANCE INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 194 FRANCE LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 195 FRANCE HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 196 FRANCE VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 197 FRANCE VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 198 FRANCE VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 199 FRANCE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 200 U.K. VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 201 U.K. NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 202 U.K. NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 203 U.K. NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 204 U.K. ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 205 U.K. HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 206 U.K. HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 207 U.K. HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 208 U.K. VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 209 U.K. INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 210 U.K. LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 211 U.K. HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 212 U.K. VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 213 U.K. VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 214 U.K. VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 215 U.K. VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 216 ITALY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 217 ITALY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 218 ITALY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 219 ITALY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 220 ITALY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 221 ITALY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 222 ITALY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 223 ITALY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 224 ITALY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 225 ITALY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 226 ITALY LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 227 ITALY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 228 ITALY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 229 ITALY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 230 ITALY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 231 ITALY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 232 RUSSIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 233 RUSSIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 234 RUSSIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 235 RUSSIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 236 RUSSIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 237 RUSSIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 238 RUSSIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 239 RUSSIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 240 RUSSIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 241 RUSSIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 242 RUSSIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 243 RUSSIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 244 RUSSIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 245 RUSSIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 246 RUSSIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 247 SPAIN VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 248 SPAIN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 249 SPAIN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 250 SPAIN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 251 SPAIN ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 SPAIN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 253 SPAIN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 254 SPAIN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 255 SPAIN VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 256 SPAIN INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 257 SPAIN LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 258 SPAIN HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 259 SPAIN VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 260 SPAIN VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 261 SPAIN VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 262 SPAIN VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 263 TURKEY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 264 TURKEY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 265 TURKEY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 266 TURKEY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 267 TURKEY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 268 TURKEY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 269 TURKEY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 270 TURKEY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 271 TURKEY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 272 TURKEY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 273 TURKEY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 274 TURKEY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 275 TURKEY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 276 TURKEY LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 277 TURKEY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 278 TURKEY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 279 TURKEY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 280 TURKEY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 281 TURKEY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 282 NETHERLANDS VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 283 NETHERLANDS NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 284 NETHERLANDS NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 285 NETHERLANDS NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 286 NETHERLANDS ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 287 NETHERLANDS HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 288 NETHERLANDS HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 289 NETHERLANDS HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 290 NETHERLANDS VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 291 NETHERLANDS INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 292 NETHERLANDS LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 293 NETHERLANDS HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 294 NETHERLANDS VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 295 NETHERLANDS VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 296 NETHERLANDS VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 297 NETHERLANDS VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 298 SWITZERLAND VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 299 SWITZERLAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 300 SWITZERLAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 301 SWITZERLAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 302 SWITZERLAND ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 303 SWITZERLAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 304 SWITZERLAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 305 SWITZERLAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 306 SWITZERLAND VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 307 SWITZERLAND INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 308 SWITZERLAND LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 309 SWITZERLAND HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 310 SWITZERLAND VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 311 SWITZERLAND VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 312 SWITZERLAND VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 313 SWITZERLAND VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 314 POLAND VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 315 POLAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 316 POLAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 317 POLAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 318 POLAND ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 319 POLAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 320 POLAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 321 POLAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 322 POLAND HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 323 POLAND HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 324 POLAND HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 325 POLAND VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 326 POLAND INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 327 POLAND LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 328 POLAND HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 329 POLAND VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 330 POLAND VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 331 POLAND VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 332 POLAND VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 333 HUNGARY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 334 HUNGARY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 335 HUNGARY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 336 HUNGARY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 337 HUNGARY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 338 HUNGARY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 339 HUNGARY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 340 HUNGARY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 341 HUNGARY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 342 HUNGARY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 343 HUNGARY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 344 HUNGARY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 345 HUNGARY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 346 HUNGARY LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 347 HUNGARY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 348 HUNGARY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 349 HUNGARY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 350 HUNGARY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 351 HUNGARY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 352 AUSTRIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 353 AUSTRIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 354 AUSTRIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 355 AUSTRIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 356 AUSTRIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 357 AUSTRIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 358 AUSTRIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 359 AUSTRIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 360 AUSTRIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 361 AUSTRIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 362 AUSTRIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 363 AUSTRIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 364 AUSTRIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 365 AUSTRIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 366 AUSTRIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 367 AUSTRIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 368 NORWAY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 369 NORWAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 370 NORWAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 371 NORWAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 372 NORWAY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 373 NORWAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 374 NORWAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 375 NORWAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 376 NORWAY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 377 NORWAY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 378 NORWAY LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 379 NORWAY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 380 NORWAY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 381 NORWAY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 382 NORWAY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 383 NORWAY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 384 IRELAND VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 385 IRELAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 386 IRELAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 387 IRELAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 388 IRELAND ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 389 IRELAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 390 IRELAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 391 IRELAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 392 IRELAND VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 393 IRELAND INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 394 IRELAND LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 395 IRELAND HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 396 IRELAND VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 397 IRELAND VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 398 IRELAND VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 399 IRELAND VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 400 LITHUANIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 401 LITHUANIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 402 LITHUANIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 403 LITHUANIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 404 LITHUANIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 405 LITHUANIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 406 LITHUANIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 407 LITHUANIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 408 LITHUANIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 409 LITHUANIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 410 LITHUANIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 411 LITHUANIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 412 LITHUANIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 413 LITHUANIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 414 LITHUANIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 415 LITHUANIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 416 LITHUANIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 417 LITHUANIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 418 LITHUANIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 419 REST OF EUROPE VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 420 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 421 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 422 ASIA-PACIFIC NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 423 ASIA-PACIFIC NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 424 ASIA-PACIFIC ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 425 ASIA-PACIFIC HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 426 ASIA-PACIFIC HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 427 ASIA-PACIFIC HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 428 ASIA-PACIFIC HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 429 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 430 ASIA-PACIFIC INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 431 ASIA-PACIFIC LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 432 ASIA-PACIFIC HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 433 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 434 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 435 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 436 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 437 CHINA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 438 CHINA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 439 CHINA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 440 CHINA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 441 CHINA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 442 CHINA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 443 CHINA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 444 CHINA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 445 CHINA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 446 CHINA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 447 CHINA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 448 CHINA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 449 CHINA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 450 CHINA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 451 CHINA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 452 CHINA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 453 INDIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 454 INDIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 455 INDIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 456 INDIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 457 INDIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 458 INDIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 459 INDIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 460 INDIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 461 INDIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 462 INDIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 463 INDIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 464 INDIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 465 INDIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 466 INDIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 467 INDIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 468 INDIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 469 INDIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 470 INDIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 471 INDIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 472 JAPAN VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 473 JAPAN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 474 JAPAN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 475 JAPAN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 476 JAPAN ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 477 JAPAN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 478 JAPAN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 479 JAPAN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 480 JAPAN VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 481 JAPAN INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 482 JAPAN HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 483 JAPAN VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 484 JAPAN VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 485 JAPAN VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 486 JAPAN VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 487 AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 488 AUSTRALIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 489 AUSTRALIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 490 AUSTRALIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 491 AUSTRALIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 492 AUSTRALIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 493 AUSTRALIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 494 AUSTRALIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 495 AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 496 AUSTRALIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 497 AUSTRALIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 498 AUSTRALIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 499 AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 500 AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 501 AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 502 AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 503 MALAYSIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 504 MALAYSIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 505 MALAYSIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 506 MALAYSIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 507 MALAYSIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 508 MALAYSIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 509 MALAYSIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 510 MALAYSIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 511 MALAYSIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 512 MALAYSIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 513 MALAYSIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 514 MALAYSIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 515 MALAYSIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 516 MALAYSIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 517 MALAYSIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 518 MALAYSIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 519 MALAYSIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 520 MALAYSIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 521 MALAYSIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 522 THAILAND VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 523 THAILAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 524 THAILAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 525 THAILAND NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 526 THAILAND ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 527 THAILAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 528 THAILAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 529 THAILAND HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 530 THAILAND HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 531 THAILAND HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 532 THAILAND HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 533 THAILAND VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 534 THAILAND INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 535 THAILAND LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 536 THAILAND HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 537 THAILAND VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 538 THAILAND VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 539 THAILAND VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 540 THAILAND VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 541 SINGAPORE VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 542 SINGAPORE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 543 SINGAPORE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 544 SINGAPORE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 545 SINGAPORE ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 546 SINGAPORE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 547 SINGAPORE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 548 SINGAPORE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 549 SINGAPORE HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 550 SINGAPORE HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 551 SINGAPORE HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 552 SINGAPORE VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 553 SINGAPORE INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 554 SINGAPORE LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 555 SINGAPORE HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 556 SINGAPORE VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 557 SINGAPORE VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 558 SINGAPORE VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 559 SINGAPORE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 560 SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 561 SOUTH KOREA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 562 SOUTH KOREA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 563 SOUTH KOREA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 564 SOUTH KOREA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 565 SOUTH KOREA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 566 SOUTH KOREA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 567 SOUTH KOREA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 568 SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 569 SOUTH KOREA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 570 SOUTH KOREA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 571 SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 572 SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 573 SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 574 SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 575 INDONESIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 576 INDONESIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 577 INDONESIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 578 INDONESIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 579 INDONESIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 580 INDONESIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 581 INDONESIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 582 INDONESIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 583 INDONESIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 584 INDONESIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 585 INDONESIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 586 INDONESIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 587 INDONESIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 588 INDONESIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 589 INDONESIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 590 INDONESIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 591 INDONESIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 592 INDONESIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 593 INDONESIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 594 PHILIPPINES VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 595 PHILIPPINES NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 596 PHILIPPINES NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 597 PHILIPPINES NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 598 PHILIPPINES ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 599 PHILIPPINES HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 600 PHILIPPINES HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 601 PHILIPPINES HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 602 PHILIPPINES HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 603 PHILIPPINES HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 604 PHILIPPINES HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 605 PHILIPPINES VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 606 PHILIPPINES INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 607 PHILIPPINES LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 608 PHILIPPINES HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 609 PHILIPPINES VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 610 PHILIPPINES VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 611 PHILIPPINES VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 612 PHILIPPINES VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 613 TAIWAN VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 614 TAIWAN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 615 TAIWAN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 616 TAIWAN NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 617 TAIWAN ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 618 TAIWAN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 619 TAIWAN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 620 TAIWAN HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 621 TAIWAN HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 622 TAIWAN HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 623 TAIWAN HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 624 TAIWAN VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 625 TAIWAN INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 626 TAIWAN LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 627 TAIWAN HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 628 TAIWAN VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 629 TAIWAN VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 630 TAIWAN VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 631 TAIWAN VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 632 VIETNAM VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 633 VIETNAM NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 634 VIETNAM NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 635 VIETNAM NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 636 VIETNAM ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 637 VIETNAM HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 638 VIETNAM HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 639 VIETNAM HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME, 2020-2029 (ASP, USD)

TABLE 640 VIETNAM HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 641 VIETNAM HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 642 VIETNAM HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 643 VIETNAM VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 644 VIETNAM INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 645 VIETNAM LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 646 VIETNAM HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 647 VIETNAM VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 648 VIETNAM VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 649 VIETNAM VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 650 VIETNAM VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 651 REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 652 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 653 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 654 SOUTH AMERICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 655 SOUTH AMERICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, VOLUME 2020-2029 (UNITS)

TABLE 656 SOUTH AMERICA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 657 SOUTH AMERICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 658 SOUTH AMERICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 659 SOUTH AMERICA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 660 SOUTH AMERICA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 661 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 662 SOUTH AMERICA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 663 SOUTH AMERICA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 664 SOUTH AMERICA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 665 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 666 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 667 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 668 SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 669 BRAZIL VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 670 BRAZIL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 671 BRAZIL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 672 BRAZIL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 673 BRAZIL ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 674 BRAZIL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 675 BRAZIL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 676 BRAZIL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 677 BRAZIL VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 678 BRAZIL INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 679 BRAZIL HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 680 BRAZIL VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 681 BRAZIL VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 682 BRAZIL VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 683 BRAZIL VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 684 COLOMBIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 685 COLOMBIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 686 COLOMBIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 687 COLOMBIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 688 COLOMBIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 689 COLOMBIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 690 COLOMBIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 691 COLOMBIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 692 COLOMBIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 693 COLOMBIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 694 COLOMBIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 695 COLOMBIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 696 COLOMBIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 697 COLOMBIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 698 COLOMBIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 699 COLOMBIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 700 COLOMBIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 701 COLOMBIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 702 COLOMBIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 703 ARGENTINA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 704 ARGENTINA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 705 ARGENTINA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 706 ARGENTINA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 707 ARGENTINA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 708 ARGENTINA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 709 ARGENTINA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 710 ARGENTINA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 711 ARGENTINA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 712 ARGENTINA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 713 ARGENTINA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 714 ARGENTINA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 715 ARGENTINA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 716 ARGENTINA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 717 ARGENTINA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 718 CHILE VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 719 CHILE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 720 CHILE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 721 CHILE NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 722 CHILE ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 723 CHILE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 724 CHILE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 725 CHILE HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 726 CHILE VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 727 CHILE INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 728 CHILE HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 729 CHILE VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 730 CHILE VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 731 CHILE VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 732 CHILE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 733 ECUADOR VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 734 ECUADOR NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 735 ECUADOR NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 736 ECUADOR NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 737 ECUADOR ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 738 ECUADOR HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 739 ECUADOR HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 740 ECUADOR HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 741 ECUADOR HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 742 ECUADOR HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 743 ECUADOR HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 744 ECUADOR VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 745 ECUADOR INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 746 ECUADOR LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 747 ECUADOR HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 748 ECUADOR VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 749 ECUADOR VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 750 ECUADOR VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 751 ECUADOR VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 752 URUGUAY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 753 URUGUAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 754 URUGUAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 755 URUGUAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 756 URUGUAY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 757 URUGUAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 758 URUGUAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 759 URUGUAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 760 URUGUAY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 761 URUGUAY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 762 URUGUAY HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 763 URUGUAY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 764 URUGUAY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 765 URUGUAY LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 766 URUGUAY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 767 URUGUAY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 768 URUGUAY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 769 URUGUAY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 770 URUGUAY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 771 PERU VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 772 PERU NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 773 PERU NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 774 PERU NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 775 PERU ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 776 PERU HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 777 PERU HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 778 PERU HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 779 PERU VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 780 PERU INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 781 PERU HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 782 PERU VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 783 PERU VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 784 PERU VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 785 PERU VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 786 VENEZUELA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 787 VENEZUELA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 788 VENEZUELA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 789 VENEZUELA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 790 VENEZUELA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 791 VENEZUELA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 792 VENEZUELA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 793 VENEZUELA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 794 VENEZUELA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 795 VENEZUELA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 796 VENEZUELA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 797 VENEZUELA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 798 VENEZUELA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 799 VENEZUELA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 800 VENEZUELA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 801 BOLIVIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 802 BOLIVIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 803 BOLIVIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 804 BOLIVIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 805 BOLIVIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 806 BOLIVIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 807 BOLIVIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 808 BOLIVIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 809 BOLIVIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 810 BOLIVIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 811 BOLIVIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 812 BOLIVIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 813 BOLIVIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 814 BOLIVIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 815 BOLIVIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 816 PARAGUAY VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 817 PARAGUAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 818 PARAGUAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 819 PARAGUAY NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 820 PARAGUAY ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 821 PARAGUAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 822 PARAGUAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 823 PARAGUAY HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 824 PARAGUAY VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 825 PARAGUAY INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 826 PARAGUAY HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 827 PARAGUAY VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 828 PARAGUAY VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 829 PARAGUAY VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 830 PARAGUAY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 831 TRINIDAD AND TOBAGO VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 832 TRINIDAD AND TOBAGO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 833 TRINIDAD AND TOBAGO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 834 TRINIDAD AND TOBAGO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 835 TRINIDAD AND TOBAGO ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 836 TRINIDAD AND TOBAGO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 837 TRINIDAD AND TOBAGO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 838 TRINIDAD AND TOBAGO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 839 TRINIDAD AND TOBAGO VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 840 TRINIDAD AND TOBAGO INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 841 TRINIDAD AND TOBAGO HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 842 TRINIDAD AND TOBAGO VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 843 TRINIDAD AND TOBAGO VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 844 TRINIDAD AND TOBAGO VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 845 TRINIDAD AND TOBAGO VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 846 CURAÇAO VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 847 CURAÇAO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 848 CURAÇAO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 849 CURAÇAO NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 850 CURAÇAO ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 851 CURAÇAO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 852 CURAÇAO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 853 CURAÇAO HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 854 CURAÇAO VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 855 CURAÇAO INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 856 CURAÇAO HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 857 CURAÇAO VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 858 CURAÇAO VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 859 CURAÇAO VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 860 CURAÇAO VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 861 REST OF SOUTH AMERICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 862 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 863 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 864 MIDDLE EAST AND AFRICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 865 MIDDLE EAST AND AFRICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 866 MIDDLE EAST AND AFRICA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 867 MIDDLE EAST AND AFRICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 868 MIDDLE EAST AND AFRICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 869 MIDDLE EAST AND AFRICA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 870 MIDDLE EAST AND AFRICA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 871 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 872 MIDDLE EAST AND AFRICA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 873 MIDDLE EAST AND AFRICA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 874 MIDDLE EAST AND AFRICA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 875 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 876 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 877 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 878 MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 879 SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 880 SOUTH AFRICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 881 SOUTH AFRICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 882 SOUTH AFRICA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 883 SOUTH AFRICA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 884 SOUTH AFRICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 885 SOUTH AFRICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 886 SOUTH AFRICA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 887 SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 888 SOUTH AFRICA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 889 SOUTH AFRICA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 890 SOUTH AFRICA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 891 SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 892 SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 893 SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 894 SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 895 EGYPT VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 896 EGYPT NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 897 EGYPT NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 898 EGYPT NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 899 EGYPT ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 900 EGYPT HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 901 EGYPT HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 902 EGYPT HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 903 EGYPT HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 904 EGYPT HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 905 EGYPT HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 906 EGYPT VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 907 EGYPT INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 908 EGYPT LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 909 EGYPT HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 910 EGYPT VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 911 EGYPT VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 912 EGYPT VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 913 EGYPT VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 914 SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 915 SAUDI ARABIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 916 SAUDI ARABIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 917 SAUDI ARABIA NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 918 SAUDI ARABIA ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 919 SAUDI ARABIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 920 SAUDI ARABIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 921 SAUDI ARABIA HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 922 SAUDI ARABIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 923 SAUDI ARABIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 924 SAUDI ARABIA HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 925 SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 926 SAUDI ARABIA INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 927 SAUDI ARABIA LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 928 SAUDI ARABIA HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 929 SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 930 SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 931 SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 932 SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 933 U.A.E VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 934 U.A.E NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 935 U.A.E NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 936 U.A.E NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 937 U.A.E ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 938 U.A.E HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 939 U.A.E HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 940 U.A.E HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 941 U.A.E HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 942 U.A.E HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 943 U.A.E HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 944 U.A.E VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 945 U.A.E INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 946 U.A.E LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 947 U.A.E HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 948 U.A.E VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 949 U.A.E VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 950 U.A.E VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 951 U.A.E VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 952 ISRAEL VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 953 ISRAEL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 954 ISRAEL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 955 ISRAEL NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 956 ISRAEL ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 957 ISRAEL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 958 ISRAEL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 959 ISRAEL HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 960 ISRAEL VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 961 ISRAEL INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 962 ISRAEL LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 963 ISRAEL HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 964 ISRAEL VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 965 ISRAEL VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 966 ISRAEL VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 967 ISRAEL VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 968 KUWAIT VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 969 KUWAIT NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 970 KUWAIT NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 971 KUWAIT NON-ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP,USD)

TABLE 972 KUWAIT ANIMAL ORIGIN IN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 973 KUWAIT HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 974 KUWAIT HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 975 KUWAIT HYLAN G-F 20 IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 976 KUWAIT HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 977 KUWAIT HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (UNITS)

TABLE 978 KUWAIT HYALURONANS IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (ASP, USD)

TABLE 979 KUWAIT VISCOSUPPLEMENTATION MARKET, BY MOLECULAR WEIGHT, 2020-2029 (USD MILLION)

TABLE 980 KUWAIT INTERMEDIATE MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 981 KUWAIT LOW MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 982 KUWAIT HIGH MOLECULAR WEIGHT IN VISCOSUPPLEMENTATION MARKET, BY BRAND, 2020-2029 (USD MILLION)

TABLE 983 KUWAIT VISCOSUPPLEMENTATION MARKET, BY INJECTION, 2020-2029 (USD MILLION)

TABLE 984 KUWAIT VISCOSUPPLEMENTATION MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 985 KUWAIT VISCOSUPPLEMENTATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 986 KUWAIT VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 987 REST OF MIDDLE EAST AND AFRICA VISCOSUPPLEMENTATION MARKET, BY SOURCE, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Viscosupplementation Market will surge by an 8.5% CAGR forecast from 2022 to 2029.
The Viscosupplementation Market report will be segmented by Source, Age Group, Injection, Molecular Weight, End User, Distribution Channel
North America is dominating due to the presence of key market players in the largest consumer market with high GDP.
The U.S is expected to grow due to the rise in technological advancement in drug treatments.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials